CD47 and cancer: The potency and the therapeutic effects of anti-CD47 agents varied between different studies according to the type of cancer, type of antibodies, stage of tumor, type of tumor model, drug pharmacokinetics, acquired drug resistanc,e and the state of the immune system [80].